000

HLB PANAGENE

No trades
See on Supercharts

046210 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

HLB PANAGENE Co., Ltd. engages in the molecular diagnostics business. It develops, manufactures and sells peptide nucleic acid (PNA) genetic diagnostic chips. The firm operates through the PNA Materials and Diagnostic Product business divisions. Its products are marketed as PANAMutyper, PNAClamp, PANArray, PANA qPCR, PNA Oligo and Monomer. The company was founded on April 16, 2001 and is headquartered in Daejeon, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

046210 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company